Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6247 USD | -9.15% | -5.82% | -17.42% |
14/05 | Citius Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
26/04 | Citius Pharmaceuticals Launches $15 Million Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.42% | 124M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- CTXR Stock
- News Citius Pharmaceuticals, Inc.
- HC Wainwright Adjusts Citius Pharmaceuticals Price Target to $6 From $4, Maintains Buy Rating